Status:

COMPLETED

Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency

Lead Sponsor:

Eli Lilly and Company

Conditions:

Adult Growth Hormone Deficiency

Eligibility:

All Genders

18-65 years

Phase:

PHASE3

Brief Summary

To evaluate long-term safety of growth hormone replacement in adult patients with growth hormone deficiency

Eligibility Criteria

Inclusion

  • Having completed the preceding long-term study of growth hormone replacement in adult patients diagnosed with growth hormone deficiency.
  • Other pituitary hormone deficiencies being replaced if appropriate

Exclusion

  • With severe impairments of cardiac, pulmonary, renal or hepatic functions
  • With severe psychological disorders
  • With malignant cancer
  • With hypertension uncontrolled
  • With diabetes mellitus

Key Trial Info

Start Date :

January 1 2003

Trial Type :

INTERVENTIONAL

End Date :

May 1 2006

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT00191360

Start Date

January 1 2003

End Date

May 1 2006

Last Update

November 6 2007

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Fukuoka, Japan

2

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Gunma, Japan

3

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Hokkaido, Japan

4

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician

Hyōgo, Japan